Key result
Artificial intelligence models in ECMO care outperformed conventional clinical scores, achieving a pooled AUROC of 0.838 for initiation prediction and >0.80 for mortality prediction.
Why the study?
ECMO is a labor-intensive therapy with high costs, significant mortality risks, and complex decision-making regarding outcome prediction and resource allocation. Artificial intelligence and machine learning offer novel approaches to improve outcome prediction, patient monitoring, and complication detection in ECMO care.
Do artificial intelligence or machine learning models improve the accuracy of predicting ECMO initiation, mortality, complications, and weaning success compared with conventional clinical scores in patients receiving ECMO?
Do artificial intelligence or machine learning models improve the accuracy of predicting ECMO initiation, mortality, complications, and weaning success compared with conventional clinical scores in patients receiving ECMO?
Answers are grounded in this paper and cite their sources.
AI-based models show improved accuracy over conventional clinical scores for predicting ECMO initiation, mortality, complications, and weaning success, though multicenter validation and prospective trials are still needed.
Extracorporeal membrane oxygenation (ECMO) is a life-saving modality used in severe cardiac and respiratory failure.Despite its benefits, it is a labor-intensive therapy in which patients face high costs and significant mortality risks.Decision-making in ECMO is also complex regarding predicting outcomes and resource allocation.Artificial intelligence (AI) offers novel approaches to improve outcome prediction, patient monitoring, and complication detection.Relevant studies evaluating AI or machine learning (ML) applications in ECMO were identified, screened, and analyzed to provide a broad contextual narrative overview.AI-based models demonstrated improved accuracy for predicting ECMO initiation, mortality, complications, and weaning success compared with conventional clinical scores.The findings suggested that AI can enhance ECMO care by supporting complex clinical decisions.However, challenges remain regarding data heterogeneity, validation, and implementation.AI enhances ECMO decision-making but requires further validation.It has significant potential to augment ECMO management.Future research should emphasize multicenter validation and prospective trials.
No takes yet. Share an insight, caveat, or question.
Khandelwal et al. (2026) conducted a review in Severe cardiac and respiratory failure requiring extracorporeal membrane oxygenation (ECMO). Artificial intelligence and machine learning prediction models vs. Conventional clinical scoring systems (e.g., RESP, PRESERVE, SOFA scores) was evaluated. Artificial intelligence models in ECMO care outperformed conventional clinical scores, achieving a pooled AUROC of 0.838 for initiation prediction and >0.80 for mortality prediction.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: